Strain 2 guinea-pigs were inoculated with infectious varicella-zoster virus (VZV) or with immunoaffinity-purified proteins of VZV. Monoclonal antibodies to the VZV gpI (90000/58000 complex) and to a non-glycosylated protein, pl70, were used to prepare the polypeptide antigens. Humoral and cell-mediated immune responses to the infectious virus were compared with those elicited by the gpI and pl70 proteins. Both VZV IgG antibody production and T lymphocyte proliferation to VZV were detected after immunization with infectious VZV and with VZV proteins. The antibody and T lymphocyte responses waned after protein immunization in comparison with the responses induced by infectious VZV but were detected again immediately after reimmunization with gpI or p170.
ArvinA. M.,
KoropchakC. M.1980; Immunoglobulins M and G to varicella-zoster virus measured by solid phase radioimmunoassay: antibody responses to varicella and herpes zoster infections. Journal of Clinical Microbiology 12:367–374
ArvinA. M.,
MartinD. P.,
GardE. A.,
MeriganT. C.1983; Interferon prophylaxis for simian varicella infection in Erthrocebus patasmonkeys. Journal of Infectious Diseases 147:149–154
ArvinA. M.,
Kinney-ThomasE.,
ShriverK.,
GroseC.,
KoropchakC. M.,
ScrantonE.,
WitterA. E.,
DiazP. S.1986; Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118) and to a nonglycosylated protein, p 170. Journal of Immunology 137:1346–1351
BiaF. J.,
GriffithB. P.,
FongC. K. Y.,
HsiungG. D.1983; Cytomegaloviral infections in the guinea pig: experimental models for human disease. Reviews of Infectious Diseases 5:177–195
DavisonA. I.,
EdsonC. M.,
EllisR. W.,
ForghaniB.,
GildenD.,
GroseC.,
KellerP. M.,
VafaiA.,
WroblewskaZ.,
YamanishiK.1986; A new nomenclature for the glycoprotein genes of varicella-zoster virus and their glycosylated products. Journal of Virology 57:1195–1197
DonnenbergA. D.,
BellE.,
AurelianL.1980; Immunity to herpes simplex virus type-2.1. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2 infected guinea-pigs. Cellular Immunology 56:526–539
EminiE. A.,
KaoS.-y.,
LewisA. J.,
CrainicR.,
WimmerE.1983; The functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies. Journal of Virology 46:466–474
FriedrichsW. E.,
GroseC.1984; Glycoprotein gp 118 of varicella-zoster virus: purification by serial affinity chromatography. Journal of Virology 49:992–996
GershonA. A.,
SteinbergS. P.,
GelbL.,
GalassoG.,
BorkowskyW.,
LarussaP.,
FerarraA.1984; Live attenuated varicella vaccine: efficacy for children with leukemia in remission. Journal of the American Medical Association 252:355–362
KellerP. M.,
NeffB. J.,
EllisR. W.1984; Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. Journal of Virology 52:293–297
KellerP. M.,
LonerganK.,
NeffB. J.,
MortonD. A.,
EllisR. W.1986; Purification of individual varicellazoster virus (VZV) glycoproteins gpl, gpll and gpIII and their use in ELISA for detection of VZV glycoprotein specific antibodies. Journal of Virological Methods 14:177–188
MatsunagaY.,
YamanishiK.,
TakahashiM.1982; Experimental infection and immune response of guinea- pigs with varicella-zoster virus. Infection and Immunity 37:407–412
SchrierR. D.,
PizerL. I.,
MoorheadI. W.1983; Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. Journal of Immunology 130:1413–1418
TownsendA. R. M.,
McmichaelA. J.,
CarterN. P.,
HuddlestonI. A.,
BrownleeG. G.1984; Cytotoxic T-cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell 39:13–25
YewdellJ. W.,
BennickJ. R.,
MackettM.,
LefrancoisL.,
LylesD. S.,
MossB.1986; Recognition of clones of vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes. Journal of Experimental Medicine 163:1529–1534